Tvardi Therapeutics, Inc. - Common Stock (NQ:TVRD)
3.970
+0.120
(+3.12%)
Streaming Delayed Price
Updated: 2:48 PM EST, Feb 26, 2026
Add to My Watchlist
Price and Volume
Detailed Quote| Volume | 34,351 |
| Open | 3.870 |
| Bid (Size) | 3.950 (400) |
| Ask (Size) | 4.000 (200) |
| Prev. Close | 3.850 |
| Today's Range | 3.750 - 4.020 |
| 52wk Range | 3.500 - 43.65 |
| Shares Outstanding | 1,524,535 |
| Dividend Yield | N/A |
Top News
More News
Performance
More News
Read More
Unusual volume stocks in Monday's session ↗
October 20, 2025
In today's session, these stocks are experiencing unusual volume. ↗
October 16, 2025
Unusual volume stocks in Wednesday's session ↗
October 15, 2025
12 Health Care Stocks Moving In Tuesday's Pre-Market Session ↗
October 14, 2025
Frequently Asked Questions
Is Tvardi Therapeutics, Inc. - Common Stock publicly traded?
Yes, Tvardi Therapeutics, Inc. - Common Stock is publicly traded.
What exchange does Tvardi Therapeutics, Inc. - Common Stock trade on?
Tvardi Therapeutics, Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Tvardi Therapeutics, Inc. - Common Stock?
The ticker symbol for Tvardi Therapeutics, Inc. - Common Stock is TVRD on the Nasdaq Stock Market
What is the current price of Tvardi Therapeutics, Inc. - Common Stock?
The current price of Tvardi Therapeutics, Inc. - Common Stock is 3.970
When was Tvardi Therapeutics, Inc. - Common Stock last traded?
The last trade of Tvardi Therapeutics, Inc. - Common Stock was at 02/26/26 02:48 PM ET
What is the market capitalization of Tvardi Therapeutics, Inc. - Common Stock?
The market capitalization of Tvardi Therapeutics, Inc. - Common Stock is 6.05M
How many shares of Tvardi Therapeutics, Inc. - Common Stock are outstanding?
Tvardi Therapeutics, Inc. - Common Stock has 6M shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.